At Africazine, we're proud to be your Africa voice, delivering the latest news and stories that matter from the vibrant and diverse continent of Africa.
At Africazine, we're proud to be your Africa voice, delivering the latest news and stories that matter from the vibrant and diverse continent of Africa.
At Africazine, we're proud to be your Africa voice, delivering the latest news and stories that matter from the vibrant and diverse continent of Africa.
At Africazine, we're proud to be your Africa voice, delivering the latest news and stories that matter from the vibrant and diverse continent of Africa.
Discover the results of a randomized non-inferiority trial conducted in The Gambia, demonstrating that a two-dose primary schedule of the pneumococcal conjugate vaccine (PCV13) offers comparable clinical protection to traditional vaccination methods. Source: Africazine.